Burrows GD - Search Results

1

Monoamine oxidase inhibitors (MAOI) or reversible inhibitors of monoamine oxidase (RIMA)/tricyclic antidepressant (TCA) combination therapy.

Tiller JW, Mitchell P, Burrows GD. Tiller JW, et al. Among authors: burrows gd. Aust N Z J Psychiatry. 1992 Jun;26(2):327-9. doi: 10.3109/00048679209072051. Aust N Z J Psychiatry. 1992. PMID: 1642632 No abstract available.

2

Dual action antidepressants and some important considerations.

Gupta RK, Tiller JW, Burrows GD. Gupta RK, et al. Among authors: burrows gd. Aust N Z J Psychiatry. 2003 Apr;37(2):190-5. doi: 10.1046/j.1440-1614.2003.01169.x. Aust N Z J Psychiatry. 2003. PMID: 12656958 Review.

3

Cade's observation of the antimanic effect of lithium and early Australian research.

Burrows GD, Tiller JW. Burrows GD, et al. Aust N Z J Psychiatry. 1999 Dec;33 Suppl:S27-31. doi: 10.1111/j.1440-1614.1999.00665.x. Aust N Z J Psychiatry. 1999. PMID: 10622176

4

Pharmacological approaches to the management of schizophrenia: 10 years on.

Castle D, Keks N, Newton R, Schweitzer I, Copolov D, Paoletti N, Burrows G, Tiller J. Castle D, et al. Australas Psychiatry. 2013 Aug;21(4):329-34. doi: 10.1177/1039856213486211. Epub 2013 Apr 24. Australas Psychiatry. 2013. PMID: 23616381 Review.

5

The Royal Melbourne Hospital Lithium Clinic.

Schweitzer I, Davies B, Burrows G, Branton L, Turecek LR, Tiller J. Schweitzer I, et al. Aust N Z J Psychiatry. 1999 Dec;33 Suppl:S35-8. doi: 10.1111/j.1440-1614.1999.00680.x. Aust N Z J Psychiatry. 1999. PMID: 10622178

6

Moclobemide for depression: an Australian psychiatric practice study.

Tiller JW, Johnson GF, Burrows GD. Tiller JW, et al. Among authors: burrows gd. J Clin Psychopharmacol. 1995 Aug;15(4 Suppl 2):31S-34S. doi: 10.1097/00004714-199508001-00006. J Clin Psychopharmacol. 1995. PMID: 7593727 Clinical Trial.

7

Beyond the evidence: is there a place for antidepressant combinations in the pharmacotherapy of depression?

Keks NA, Burrows GD, Copolov DL, Newton R, Paoletti N, Schweitzer I, Tiller J. Keks NA, et al. Among authors: burrows gd. Med J Aust. 2007 Feb 5;186(3):142-4. doi: 10.5694/j.1326-5377.2007.tb01194.x. Med J Aust. 2007. PMID: 17309404 Review.

8

Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial.

Goodwin GM, Emsley R, Rembry S, Rouillon F; Agomelatine Study Group. Goodwin GM, et al. J Clin Psychiatry. 2009 Aug;70(8):1128-37. doi: 10.4088/JCP.08m04548. Epub 2009 Aug 11. J Clin Psychiatry. 2009. PMID: 19689920 Clinical Trial.

9

Efficacy of venlafaxine and predictors of response in a prospective open-label study of patients with treatment-resistant major depression.

Mitchell PB, Schweitzer I, Burrows G, Johnson G, Polonowita A. Mitchell PB, et al. J Clin Psychopharmacol. 2000 Aug;20(4):483-7. doi: 10.1097/00004714-200008000-00014. J Clin Psychopharmacol. 2000. PMID: 10917411 Clinical Trial.

10

Sustained response to open-label venlafaxine in drug-resistant major depression.

Schweitzer I, Burrows G, Tuckwell V, Polonowita A, Flynn P, George T, Theodoros M, Mitchell P. Schweitzer I, et al. J Clin Psychopharmacol. 2001 Apr;21(2):185-9. doi: 10.1097/00004714-200104000-00010. J Clin Psychopharmacol. 2001. PMID: 11270915 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters